ClinicalTrials.Veeva

Menu

The Turkish Version of the AOFAS Hallux MTP-IP

I

Istanbul University - Cerrahpasa (IUC)

Status

Completed

Conditions

Orthopedic Disorder
Assessment, Self
Hallux Deformity
Foot Deformity

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The American Orthopedic Foot and Ankle Society hallux metatarsophalangeal-interphalangeal joint scale (AOFAS Hallux MTP-IP) is originally developed in English to evaluate the pain, function and alignment in patients with hallux deformities. The purpose of this study is to translate and cross-culturally adapt the AOFAS Hallux MTP-IP scale into Turkish and investigate its psychometric properties.

Full description

The American Orthopedic Foot and Ankle Society hallux metatarsophalangeal-interphalangeal joint scale (AOFAS Hallux MTP-IP) is originally developed in English to evaluate joint function in patients with elbow stiffness. The purpose of this study is to translate and cross-culturally adapt the AOFAS Hallux MTP-IP scale into Turkish and investigate its psychometric properties. Approximately seventy patients with hallux deformities will be included. For cross-cultural adaptation, two bi-lingual translators will use the back-translation procedure. Within a 5-to-7-day period after the first assessment, the participants will complete the Turkish version of AOFAS Hallux MTP-IP (AOFAS Hallux MTP-IP-T) to evaluate test-retest reliability. Cronbach's alpha (α) will use to assess internal consistency. The correlation with the Turkish version of the Manchester-Oxford Foot Questionnaire (MOXFQ) and Short Form-12 will be determined to check the validity.

Enrollment

66 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Aged between 18 and 65 years
  • Diagnosis of Hallux deformities
  • Continuing follow-up and treatment in the orthopedic service
  • Being able to follow simple instructions
  • Being able to read and write in Turkish

Exclusion criteria

  • Having any cardiovascular diseases, neurological disorders, rheumatic diseases, or psychiatric diseases
  • Having peripheral nerve injury, peripheral neuropathy, or sensory loss in the lower extremity
  • Having heterotopic ossification, myositis ossification, or post-traumatic ankylosing in the lower extremity
  • Fracture, non-healing wound, or infection in the lower extremity

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems